Pulished Date October, 2018
ID: 6192
Share on
Share on

Capecitabine Market By Application (Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, And Others), Drug Formulation (Tablets And Capsules), And Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecast To 2024

Pulished: October, 2018
ID: 6192
Pages: 175

Capecitabine market is anticipated to grow at XX% CAGR from 2018 to 2023 and it is estimated that the global market was valued at USD XX billion in 2018 and is expected to reach USD XX billion by 2023.

Capecitabine is a chemotherapy drug used in the treatment of cancers such as gastric cancer, colorectal cancer, and breast cancer. It acts on the cancer cells and not only does it prevents them from further multiplying, buts also helps in destroying the cancer cells.

Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of capecitabine drive the growth of the capecitabine market. According to the National Cancer Institute around 135,430 people are estimated to suffer from colon and rectum cancer and 50,260 people died of colon and rectum cancer in 2018 in the U.S. Furthermore, rise in healthcare expenditure and increase in investment in cancer treatment or assisted programs by governments and private organizations such as Cancer Care and Cancer Suraksha Scheme are anticipated to boost the market growth. However, high cost of capecitabine, adverse effects, presence of substitutes, such as raltitrexed and leucovorin, and stringent government regulations related to the safety and efficacy of capecitabine hinder the market growth. Ongoing R&D activities related to capecitabine are anticipated to present new opportunities for the market.

The global Capecitabine market is segmented on the basis of Application and Drug Formulation. On the basis of Application, the market is segmented into Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, and Others. On the basis of Drug Formulation, the market is segmented into Tablets and Capsules.

On the basis of geography, the Capecitabine market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounted for the largest share of the Capecitabine market followed by Europe and Asia Pacific. Asia Pacific is expected to witness the highest CAGR in the coming years.

The market is dominated by companies like Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Colon Cancer          

                                5.1.3 Rectal Cancer         

                                5.1.4 Breast Cancer        

                                5.1.5 Gastric Cancer       

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Application         

                                5.1.8 Market Attractiveness Analysis, By Application       

                                5.1.9 Market Share Analysis, By Application        

                5.2 Drug Formulation                     

                                5.2.1 Introduction           

                                5.2.2 Tablets      

                                5.2.3 Capsules  

                                5.2.4 Y-o-Y Growth Analysis, By Drug Formulation            

                                5.2.5 Market Attractiveness Analysis, By Drug Formulation          

                                5.2.6 Market Share Analysis, By Drug Formulation            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Drug Formulation

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Drug Formulation

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Drug Formulation

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Novartis AG                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Sensus Healthcare                   

                8.3 RXi Pharmaceuticals Inc.                       

                8.4 Sonoma Pharmaceuticals Inc.                             

                8.5 Perrigo Company plc                              

                8.6 Bristol-Myers Squibb Company                         

                8.7 Pacific World Corporation                     

                8.8 Valeant Pharmaceuticals International Inc.                   

                8.9 Revitol Corporation                 

                8.10 Avita Medical Limited.                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Global Capecitabine  Market By Region, From 2019-2024 ( USD Million )
  2. Global Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  3. Global Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  4. Global Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  5. Global Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  6. Global Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  7. Global Others Market By Region, From 2019-2024 ( USD Million )
  8. Global Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  9. Global Tablets Market By Region, From 2019-2024 ( USD Million )
  10. Global Capsules Market By Region, From 2019-2024 ( USD Million )
  11. North America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  12. North America Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  13. North America Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  14. North America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  15. North America Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  16. North America Others Market By Region, From 2019-2024 ( USD Million )
  17. North America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  18. North America Tablets Market By Region, From 2019-2024 ( USD Million )
  19. North America Capsules Market By Region, From 2019-2024 ( USD Million )
  20. United States Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  21. United States Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  22. Canada Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  23. Canada Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  24. Europe Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  25. Europe Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  26. Europe Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  27. Europe Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  28. Europe Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  29. Europe Others Market By Region, From 2019-2024 ( USD Million )
  30. Europe Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  31. Europe Tablets Market By Region, From 2019-2024 ( USD Million )
  32. Europe Capsules Market By Region, From 2019-2024 ( USD Million )
  33. U.K. Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  34. U.K. Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  35. Germany Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  36. Germany Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  37. France Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  38. France Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  39. Italy Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  40. Italy Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  41. Spain Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  42. Spain Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  43. Asia Pacific Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  44. Asia Pacific Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  45. Asia Pacific Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  46. Asia Pacific Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  47. Asia Pacific Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  48. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  49. Asia Pacific Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  50. Asia Pacific Tablets Market By Region, From 2019-2024 ( USD Million )
  51. Asia Pacific Capsules Market By Region, From 2019-2024 ( USD Million )
  52. Japan Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  53. Japan Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  54. China Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  55. China Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  56. India Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  57. India Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  58. Australia Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  59. Australia Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  60. South Korea Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  61. South Korea Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  62. Latin America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  63. Latin America Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  64. Latin America Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  65. Latin America Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  66. Latin America Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  67. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  68. Latin America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  69. Latin America Tablets Market By Region, From 2019-2024 ( USD Million )
  70. Latin America Capsules Market By Region, From 2019-2024 ( USD Million )
  71. Brazil Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  72. Brazil Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  73. Argentina Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  74. Argentina Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  75. Mexico Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  76. Mexico Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  77. Rest of Latin America Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  78. Rest of Latin America Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  79. Middle East and Africa Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  80. Middle East and Africa Colon Cancer Market By Region, From 2019-2024 ( USD Million )
  81. Middle East and Africa Rectal Cancer Market By Region, From 2019-2024 ( USD Million )
  82. Middle East and Africa Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  83. Middle East and Africa Gastric Cancer Market By Region, From 2019-2024 ( USD Million )
  84. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  85. Middle East and Africa Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  86. Middle East and Africa Tablets Market By Region, From 2019-2024 ( USD Million )
  87. Middle East and Africa Capsules Market By Region, From 2019-2024 ( USD Million )
  88. Middle East Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  89. Middle East Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )
  90. Africa Capecitabine  Market By Application, From 2019-2024 ( USD Million )
  91. Africa Capecitabine  Market By Drug Formulation, From 2019-2024 ( USD Million )

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients

Research Areas